Aikawa M, Rabkin E, Voglic S J, Shing H, Nagai R, Schoen F J, Libby P
Vascular Medicine and Atherosclerosis Unit, Cardiovascular Division, Departments of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass, USA.
Circ Res. 1998 Nov 16;83(10):1015-26. doi: 10.1161/01.res.83.10.1015.
Smooth muscle cells (SMCs) in the atherosclerotic intima characteristically differ from those in the arterial media, for example, by reduced expression of SMC differentiation/maturation markers such as smooth muscle myosin heavy chain isoforms (SM1 and SM2). This study tested the hypothesis that lipid lowering promotes maturation of intimal SMCs in 33 rabbits subjected to balloon injury and cholesterol feeding (0.3%) for 4 months (Baseline group, n=15); some of which then were switched to a low-cholesterol diet for 8 months (Low group at 8 months, n=3) or 16 months (Low group at 16 months, n=10). The remaining rabbits continued to consume a high-cholesterol diet for 16 months (High group, n=5). We monitored SMC phenotype by expression of immunoreactive alpha-smooth muscle actin, SM1, and SM2. alpha-Actin is an early marker, and SM1 and SM2 are late markers for SMC differentiation/maturation. Only fully differentiated or mature SMCs express SM2. Data are reported as the percentage of the alpha-actin-positive intimal area occupied by smooth muscle myosin-positive SMCs determined by color image analysis of immunostained sections. Levels of SM1 and SM2, highly expressed by SMCs in the normal aortic media (n=5) decreased in the aortic intima of the Baseline and High groups, indicating a less mature phenotype. In contrast, SM1 and SM2 increased in the Low (16 months) group, indicating that intimal SMCs exhibit a more mature phenotype after lipid lowering. Electron microscopy also showed the presence of mature intimal SMCs with abundant myofilaments. Furthermore, lipid lowering reduced levels of platelet-derived growth factor-B in the arterial intima, a factor known to suppress smooth muscle myosin expression. These data demonstrate that lipid lowering favors accumulation of mature SMCs in the atherosclerotic intima in association with reduced levels of platelet-derived growth factor-B expression. Intimal SMCs in the Low group also displayed reduced expression of matrix metalloproteinases-3 and -9 compared with the Baseline and High groups. These findings shed new light on the effects of lipid lowering at the level of the vascular wall, which may influence the biology of the atheroma.
动脉粥样硬化内膜中的平滑肌细胞(SMC)与动脉中膜的平滑肌细胞存在特征性差异,例如,平滑肌肌球蛋白重链异构体(SM1和SM2)等SMC分化/成熟标志物的表达降低。本研究在33只接受球囊损伤并喂食胆固醇(0.3%)4个月的兔子中检验了降脂促进内膜SMC成熟的假设(基线组,n = 15);其中一些兔子随后改为低胆固醇饮食8个月(8个月低胆固醇组,n = 3)或16个月(16个月低胆固醇组,n = 10)。其余兔子继续食用高胆固醇饮食16个月(高胆固醇组,n = 5)。我们通过免疫反应性α-平滑肌肌动蛋白、SM1和SM2的表达来监测SMC表型。α-肌动蛋白是SMC分化/成熟的早期标志物,SM1和SM2是晚期标志物。只有完全分化或成熟的SMC表达SM2。数据报告为通过免疫染色切片的彩色图像分析确定的α-肌动蛋白阳性内膜区域中平滑肌肌球蛋白阳性SMC所占的百分比。正常主动脉中膜(n = 5)中SMC高度表达的SM1和SM2水平在基线组和高胆固醇组的主动脉内膜中降低,表明表型不太成熟。相比之下,低胆固醇(16个月)组中SM1和SM2增加,表明降脂后内膜SMC表现出更成熟的表型。电子显微镜也显示存在具有丰富肌丝的成熟内膜SMC。此外,降脂降低了动脉内膜中血小板衍生生长因子-B的水平,该因子已知可抑制平滑肌肌球蛋白表达。这些数据表明,降脂有利于成熟SMC在动脉粥样硬化内膜中的积累,同时血小板衍生生长因子-B表达水平降低。与基线组和高胆固醇组相比,低胆固醇组中的内膜SMC还显示出基质金属蛋白酶-3和-9的表达降低。这些发现为降脂在血管壁水平的作用提供了新的见解,这可能会影响动脉粥样硬化的生物学特性。